We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Estimates Mylan Overcharged $1.27 Billion for the EpiPen Over a Decade
HHS Estimates Mylan Overcharged $1.27 Billion for the EpiPen Over a Decade